|
A 79-year-old male with non-small cell lung cancer (nsclc) began optune lua therapy on (b)(6) 2026.On (b)(6) 2026, the patient's spouse informed novocure that the patient experienced weakness on the left side including the arm, hand, and leg immediately following the removal of the transducer arrays from the torso.On (b)(6) 2026, the spouse described the patient's symptoms as it appeared that he had no control of his movements, which lasted approximately 30 minutes.The patient was transported to the emergency room (er) where he was monitored overnight.During the hospitalization, the patient underwent diagnostic testing including a magnetic resonance imaging (mri) scan, which showed no evidence of a cerebrovascular accident or other acute findings.The er physician indicated that the event may have been related to device use.On (b)(6) 2026, the prescribing physician reported that the patient was hospitalized due to involuntary arm movements and temporarily discontinued optune lua therapy.At that time, the patient did not experience disease progression.The physician assessed that the event was likely caused by optune lua therapy.
|